The Role of Fibroblasts in Dystrophic Epidermolysis Bullosa Pathogenesis and Current Treatment Approaches
Dystrophic epidermolysis bullosa (DEB) is a hereditary skin fragility disease characterized by the loss or dysfunction of collagen VII, predisposing patients to dermal–epidermal separation. This disease is highly associated with the development of progressive fibrosis of the skin and other organs an...
Saved in:
| Main Authors: | Alexander Nyström, Celine Pattaroni, Johannes S. Kern |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | JID Innovations |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026725000074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
by: Alexander Nyström, et al.
Published: (2015-07-01) -
A Comprehensive Narrative Review of the Challenges Surrounding Cutaneous SCC
by: Sarah C. Beach, et al.
Published: (2025-06-01) -
Apoptotic Bodies Restore NAD and Mitochondrial Homeostasis in Fibroblasts
by: Shutong Qian, et al.
Published: (2025-08-01) -
Application of biomedical cell products in the treatment of congenital epidermolysis bullosa
by: Arfenya E. Karamova, et al.
Published: (2024-11-01) -
NEW BIOKERATOPROSTHETIC COMPLEX BASED ON MODIFIED ALLOGENIC DONOR CORNEAS AND CULTURED POSTNATAL HUMAN SKIN FIBROBLASTS
by: S. A. Borzenok, et al.
Published: (2011-06-01)